2024 Q2 Form 10-Q Financial Statement

#000095017024056878 Filed on May 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $78.97M $80.17M
YoY Change -12.26% -11.57%
Cost Of Revenue $40.32M $42.07M
YoY Change -10.4% -3.48%
Gross Profit $38.65M $38.10M
YoY Change -14.13% -19.05%
Gross Profit Margin 48.95% 47.53%
Selling, General & Admin $37.84M $29.42M
YoY Change 48.66% 6.22%
% of Gross Profit 97.9% 77.2%
Research & Development $3.418M $3.356M
YoY Change 4.94% 4.88%
% of Gross Profit 8.84% 8.81%
Depreciation & Amortization $2.700M $6.454M
YoY Change 12.5% -2.36%
% of Gross Profit 6.99% 16.94%
Operating Expenses $45.67M $37.15M
YoY Change 35.77% 4.04%
Operating Profit -$7.017M $957.0K
YoY Change -161.69% -91.58%
Interest Expense $17.75M $17.51M
YoY Change 9.62% 11.01%
% of Operating Profit 1829.47%
Other Income/Expense, Net
YoY Change
Pretax Income -$24.74M -$16.58M
YoY Change 450.02% 293.62%
Income Tax $600.0K $300.0K
% Of Pretax Income
Net Earnings -$25.30M -$16.88M
YoY Change 440.6% 274.42%
Net Earnings / Revenue -32.04% -21.05%
Basic Earnings Per Share -$0.58 -$0.39
Diluted Earnings Per Share -$0.58 -$0.39
COMMON SHARES
Basic Shares Outstanding 43.09M 43.09M
Diluted Shares Outstanding 43.27M 43.09M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $33.80M $18.36M
YoY Change 61.78% -30.31%
Cash & Equivalents $33.80M $18.36M
Short-Term Investments
Other Short-Term Assets $1.478M $1.806M
YoY Change 9.89% 42.09%
Inventory
Prepaid Expenses $19.35M $18.87M
Receivables $92.72M $106.3M
Other Receivables $0.00 $0.00
Total Short-Term Assets $147.3M $145.3M
YoY Change 1.38% -1.02%
LONG-TERM ASSETS
Property, Plant & Equipment $13.82M $15.30M
YoY Change -26.45% -24.96%
Goodwill $393.9M $394.6M
YoY Change 0.72% 0.77%
Intangibles $38.09M $39.15M
YoY Change -12.41% -13.23%
Long-Term Investments
YoY Change
Other Assets $7.213M $7.539M
YoY Change -19.24% -15.89%
Total Long-Term Assets $461.4M $465.6M
YoY Change -2.61% -2.32%
TOTAL ASSETS
Total Short-Term Assets $147.3M $145.3M
Total Long-Term Assets $461.4M $465.6M
Total Assets $608.8M $610.9M
YoY Change -1.68% -2.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $28.90M $31.94M
YoY Change -2.99% -1.2%
Accrued Expenses $4.708M $5.416M
YoY Change -32.41% -19.52%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $592.4M $565.7M
YoY Change 104.64% 18756.37%
Total Short-Term Liabilities $630.6M $606.8M
YoY Change 91.5% 1229.52%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $1.918M $2.123M
YoY Change 10.42% -20.04%
Total Long-Term Liabilities $1.918M $2.123M
YoY Change -99.22% -99.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $630.6M $606.8M
Total Long-Term Liabilities $1.918M $2.123M
Total Liabilities $648.2M $624.8M
YoY Change 9.44% 5.44%
SHAREHOLDERS EQUITY
Retained Earnings -$436.1M -$410.8M
YoY Change 18.41% 12.98%
Common Stock $397.0M $396.2M
YoY Change 0.84% 0.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$39.38M -$13.94M
YoY Change
Total Liabilities & Shareholders Equity $608.8M $610.9M
YoY Change -1.68% -2.02%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$25.30M -$16.88M
YoY Change 440.6% 274.42%
Depreciation, Depletion And Amortization $2.700M $6.454M
YoY Change 12.5% -2.36%
Cash From Operating Activities -$3.058M -$7.901M
YoY Change -15390.0% 159.39%
INVESTING ACTIVITIES
Capital Expenditures $3.640M $3.011M
YoY Change -9.77% 45.32%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$3.640M -$3.011M
YoY Change -9.77% 45.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 22.25M 14.25M
YoY Change -1594.29% -1210.68%
NET CHANGE
Cash From Operating Activities -3.058M -7.901M
Cash From Investing Activities -3.640M -3.011M
Cash From Financing Activities 22.25M 14.25M
Net Change In Cash 15.55M 3.010M
YoY Change -382.61% -147.9%
FREE CASH FLOW
Cash From Operating Activities -$3.058M -$7.901M
Capital Expenditures $3.640M $3.011M
Free Cash Flow -$6.698M -$10.91M
YoY Change 66.87% 113.21%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001752474
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-38789
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
KLDiscovery Inc.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
61-1898603
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
9023 Columbine Road
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Eden Prairie
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55347
CY2024Q1 dei City Area Code
CityAreaCode
703
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
288-3380
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
43086267
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18361000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15351000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3031000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3642000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
106279000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
101257000
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
18866000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
15787000
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1806000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1585000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
145312000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
133980000
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
75049000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
73045000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15299000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17261000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9045000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10078000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
39152000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
39729000
CY2024Q1 us-gaap Goodwill
Goodwill
394559000
CY2023Q4 us-gaap Goodwill
Goodwill
396283000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7539000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8262000
CY2024Q1 us-gaap Assets
Assets
610906000
CY2023Q4 us-gaap Assets
Assets
605593000
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
565691000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
546845000
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
31944000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
25957000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5416000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5906000
CY2024Q1 kldi Current Portion Of Contingent Consideration
CurrentPortionOfContingentConsideration
650000
CY2023Q4 kldi Current Portion Of Contingent Consideration
CurrentPortionOfContingentConsideration
650000
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3094000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3181000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
606795000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
582539000
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
9218000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
8941000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6713000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7870000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2123000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2176000
CY2024Q1 us-gaap Liabilities
Liabilities
624849000
CY2023Q4 us-gaap Liabilities
Liabilities
601526000
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43086267
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43086267
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43086267
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43086267
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
4000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
396242000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
395461000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-410833000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-393954000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
644000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2556000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-13943000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4067000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
610906000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
605593000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
80172000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
90659000
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
42068000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
43587000
CY2024Q1 us-gaap Gross Profit
GrossProfit
38104000
CY2023Q1 us-gaap Gross Profit
GrossProfit
47072000
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18147000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17301000
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3356000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3200000
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11268000
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10391000
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4376000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4813000
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
37147000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
35705000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
957000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
11367000
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
32000
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-191000
CY2024Q1 us-gaap Interest Expense
InterestExpense
17508000
CY2023Q1 us-gaap Interest Expense
InterestExpense
15771000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16583000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4213000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
296000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
295000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-16879000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4508000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1912000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
825000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1912000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
825000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18791000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3683000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43086267
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43086267
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42920321
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42920321
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4067000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
781000
CY2024Q1 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
-1912000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-16879000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-13943000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
33691000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
877000
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
825000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4508000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
30885000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-16879000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-4508000
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6454000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6610000
CY2024Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
6184000
CY2023Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
5156000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
747000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
833000
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1110000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
797000
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
279000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
118000
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
32000
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-191000
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6326000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7186000
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2179000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7018000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2743000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3318000
CY2024Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-66000
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-975000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7901000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3046000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3011000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2072000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3011000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2072000
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
15000000
CY2023Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
533000
CY2024Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
750000
CY2023Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
750000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14250000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1283000
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-328000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
117000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3010000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6284000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15351000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32629000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18361000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26345000
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
11352000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
10842000
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
690000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
263000
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
276000
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
751000
CY2024Q1 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
17
CY2024Q1 kldi Number Of Data Centers
NumberOfDataCenters
9
CY2024Q1 kldi Number Of Data Recovery Labs
NumberOfDataRecoveryLabs
13
CY2024Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2018-08-02
CY2024Q1 us-gaap Cash
Cash
18400000
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
569600000
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures in the condensed consolidated financial statements. Although actual results could differ from those estimates, management does not believe that such differences would be material.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Significant estimates include, but are not limited to, the allowance for doubtful accounts, determining the fair values of assets acquired and liabilities assumed, including the fair value of Private Warrants (as defined in Note 2), the determination of the incremental borrowing rate used to measure right-of-use assets and liabilities, the recoverability and useful lives of property and equipment, intangible assets, and other long-lived assets, the evaluation of goodwill for impairment, the valuation and realization of deferred income taxes, the fair value of the Company’s common stock, stock based compensation equity awards and acquisition related contingent consideration.</span></p>
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3642000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5403000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
1110000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
797000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1721000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1953000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3031000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4247000
CY2024Q1 us-gaap Depreciation
Depreciation
2700000
CY2023Q1 us-gaap Depreciation
Depreciation
2300000
CY2023Q1 kldi Amortization Of Capitalized Implementation Costs
AmortizationOfCapitalizedImplementationCosts
500000
CY2024Q1 kldi Amortization Of Capitalized Implementation Costs
AmortizationOfCapitalizedImplementationCosts
500000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3300000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3900000
CY2021Q4 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
80172000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
90659000
CY2024Q1 us-gaap Contingent Consideration Classified As Equity Fair Value Disclosure
ContingentConsiderationClassifiedAsEquityFairValueDisclosure
1300000
CY2023Q4 us-gaap Contingent Consideration Classified As Equity Fair Value Disclosure
ContingentConsiderationClassifiedAsEquityFairValueDisclosure
1300000
CY2024Q1 kldi Fair Value Of Warrants
FairValueOfWarrants
100000
CY2023Q4 kldi Fair Value Of Warrants
FairValueOfWarrants
100000
CY2024Q1 kldi Operating And Capital Lease Agreements Lease Expiring Year
OperatingAndCapitalLeaseAgreementsLeaseExpiringYear
2029
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
5179000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4107000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2453000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
802000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
702000
CY2024Q1 kldi Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
269000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
13512000
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1383000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
12129000
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
569564000
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
552676000
CY2024Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
3530000
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
5254000
CY2024Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
343000
CY2023Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
577000
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
565691000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
546845000
CY2024Q1 us-gaap Debt Current
DebtCurrent
565691000
CY2023Q4 us-gaap Debt Current
DebtCurrent
546845000
CY2024Q1 us-gaap Debt Instrument Maturity Date Description
DebtInstrumentMaturityDateDescription
The Amended 2021 Credit Agreement matures on February 8, 2026, unless the Debentures are outstanding six months prior to the December 19, 2024 maturity date thereof, in which case the Amended 2021 Credit Agreement matures on June 19, 2024. As of March 31, 2024, the Company does not anticipate repaying the Convertible Debentures by June 19, 2024 and as such, the Term Loan debt of $291.0 million, the Convertible Debentures debt of $263.6 million and the Revolving Credit Loans debt of $15.0 million are included in the current portion of long-term debt.
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
747000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
833000
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Voting Rights
CommonStockVotingRights
one vote for each share
CY2024Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0
CY2023Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.018
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.071
CY2024Q1 kldi Number Of Letters Of Credit
NumberOfLettersOfCredit
2
CY2024Q1 kldi Letters Of Credit As Additional Security For Lease Guarantees
LettersOfCreditAsAdditionalSecurityForLeaseGuarantees
600000

Files In Submission

Name View Source Status
0000950170-24-056878-index-headers.html Edgar Link pending
0000950170-24-056878-index.html Edgar Link pending
0000950170-24-056878.txt Edgar Link pending
0000950170-24-056878-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kldi-20240331.htm Edgar Link pending
kldi-20240331.xsd Edgar Link pending
kldi-ex31_1.htm Edgar Link pending
kldi-ex31_2.htm Edgar Link pending
kldi-ex32_1.htm Edgar Link pending
kldi-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
kldi-20240331_htm.xml Edgar Link completed
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending